-
New medication for Hodgkin's patients who have failed to respond to all other treatments may soon be approved
FDA Panel Endorses Novel Drug for Lymphoma
-
Study demonstrates new diagnostic method to predict survival/relapse outcomes in classic Hodgkin's Lymphoma
Madely Health Headlines Commentary for March 11, 2010 Source: B.C. team makes a breakthrough in lymphoma treatment Reference: Tumor-Associated Macrophages and Survival in Classic Hodgkin’s Lymphoma